Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3680077018 | Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3680078011 | Lapatinib ditosylate 250 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
48971901000001117 | Lapatinib 250mg tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Is a | Product containing lapatinib | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has active ingredient | Lapatinib ditosylate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has active ingredient | Lapatinib ditosylate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has basis of strength substance | Lapatinib ditosylate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has precise active ingredient | Lapatinib ditosylate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Is a | Product containing only lapatinib in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has active ingredient | Lapatinib | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has active ingredient | Lapatinib ditosylate monohydrate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has specific active ingredient | Lapatinib ditosylate monohydrate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has specific active ingredient | Lapatinib ditosylate monohydrate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Lapatinib | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Tyverb 250mg tablets (GlaxoSmithKline) | Is a | False | Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Lapatinib 250mg tablets 70 tablet | Is pack of | False | Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Lapatinib 250mg tablets 70 tablet | Has VMP | False | Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Lapatinib 250mg tablets 84 tablet | Has VMP | False | Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Lapatinib 250mg tablets 105 tablet | Has VMP | False | Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets